Description
AROTIN-24 SR (Betahistine Dihydrochloride Sustained Release Tablets) is a trusted pharmaceutical formulation used for the management of vertigo, Ménière’s disease, dizziness, tinnitus, and balance-related disorders. Each sustained-release tablet contains Betahistine Dihydrochloride 24 mg, a well-established medication that helps improve blood circulation in the inner ear and reduces pressure buildup responsible for vertigo symptoms. The sustained-release technology ensures gradual drug release, providing prolonged therapeutic action and enhanced patient compliance.
Betahistine works by acting on histamine receptors and improving microcirculation within the vestibular system. It helps reduce the frequency and severity of vertigo attacks while alleviating symptoms such as ringing in the ears and hearing disturbances. Key benefits of AROTIN-24 SR include long-lasting relief, improved balance, reduced dizziness episodes, and better quality of life for patients suffering from vestibular disorders.
Dosage and Administration
AROTIN-24 SR should be taken strictly as prescribed by a healthcare professional. The tablet should be swallowed whole with water and should not be crushed or chewed, as this may affect its sustained-release properties. Dosage may vary depending on the patient’s medical condition, age, and response to treatment. Regular use as directed helps achieve optimal therapeutic results.
Possible Side Effects
Like all medicines, AROTIN-24 SR may cause some side effects, although not everyone experiences them. Common side effects may include nausea, headache, indigestion, stomach discomfort, bloating, or mild gastrointestinal disturbances. These effects are generally temporary and resolve on their own. Patients should consult a healthcare professional if any side effects persist or worsen.
Betahistine Dihydrochloride Sustained Release Tablets PCD Pharma Franchise – Arrowin Pharmaceuticals
Arrowin Pharmaceuticals offers lucrative opportunities for entrepreneurs, distributors, and pharma professionals seeking a Betahistine Dihydrochloride Sustained Release Tablets PCD Pharma Franchise. With a commitment to quality manufacturing, attractive monopoly rights, timely delivery, and comprehensive marketing support, Arrowin Pharmaceuticals empowers franchise partners to build a successful pharmaceutical business. Partner with Arrowin Pharmaceuticals and expand your portfolio with high-quality healthcare products backed by trust, innovation, and customer satisfaction.
